News & Events
Article: Beyond the lab: trust, storytelling and the fight for America’s attention
In a World View article published in Nature Reviews Immunology, Science & Society Program Executive Director Aaron F. Mertz and Associate Professor at Icahn School of Medicine at Mount Sinai Shruti [read more]
Request for Proposals: Third Annual Renée Fleming Neuroarts Investigator Awards to Advance Arts and Health Research
NeuroArts Blueprint
The Renée Fleming Foundation in partnership with the NeuroArts Blueprint Initiative is offering year two of the Renée Fleming Neuroarts Investigator Awards. The Awards support innovative and collaborative research by early career researchers, [read more]
Press Release: NeuroArts Blueprint Initiative Launches Nationwide Network of Community Neuroarts Coalitions
NeuroArts Blueprint
On November 12, the NeuroArts Blueprint Initiative launched the Community Neuroarts Coalitions (CNC) Network to support 11 communities across the U.S. using the power of the arts to improve health and well-being. [read more]
News Article: Medicare Can’t Afford Not To Cover Ozempic
A decision for whether Medicare will cover a revolutionary new class of weight-loss treatments, which include drugs like Zepbound and Wegovy, could be imminent, according to Dr. Mehmet Oz, head of the Centers for Medicare [read more]
News Article: CMS Administrator Dr. Oz on GLP-1 for weight loss in Medicare: You’ll be hearing more soon
CMS Administrator Dr. Mehmet Oz addressed the rising discussion around covering GLP-1 medications (like Ozempic and Wegovy) for weight loss under Medicare. Citing “a lot of action” in the space, Oz confirmed that a decision [read more]
News Article: Oz speaks out about shutdown, Medicaid cuts, Medicare Advantage audits and more
At Public Health Grand Rounds at the Aspen Institute on October 6, Dr. Mehmet Oz addressed the fallout of the government shutdown and stood by key Republican policy decisions. Learn his position on the expiring [read more]
